Sunday, September 13, 2026

Nikkei 225 Jumps By 5% In The Last 5 Sessions

ViaNews Editorial Team

November 7, 2023

Nikkei 225 Jumps By 5% In The Last 5 Sessions

(VIANEWS) - Nikkei 225 (N225) has been up by 5.69% for the last 5 sessions. At 05:08 EST on Tuesday, 7 November, Nikkei 225 (N225) is $32,444.95.

Concerning Nikkei 225's yearly highs and lows, it's 26.43% up from its 52-week low and 3.93% down from its 52-week high.

Volatility

Nikkei 225's last week, last month's, and last quarter's current intraday variation average was 1.96%, 0.29%, and 0.97%, respectively.

Nikkei 225's highest amplitude of average volatility was 1.96% (last week), 1.24% (last month), and 0.97% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Nikkei 225's is considered to be oversold (<=20).

News about

  • According to MarketWatch on Monday, 6 November, "The company has applied to list on Nasdaq under the ticker "CRGX." The Renaissance IPO ETF has gained 29% in the year to date, while the S&P 500 has gained 13.5%."
  • According to MarketWatch on Monday, 6 November, "In comparison, the Global X Autonomous & Electric Vehicles ETF DRIV has gained 12.3% this year and the S&P 500 index SPX has advanced 13.5%."
  • According to Zacks on Monday, 6 November, "The S&P 500 advanced 5.9%, the Dow Jones added 5.1%, the Nasdaq surged 6.6% and the Russell 2000 jumped about 7% last week on hopes that the Fed is done with its rate-hiking campaign due to weak jobs data. "
  • According to MarketWatch on Monday, 6 November, "The stock has tumbled 27.7% over the past three months through Friday, while the S&P 500 has slipped 2.7%."
  • According to MarketWatch on Monday, 6 November, "Organigram's stock has fallen 64% in the year to date, while the AXS Cannabis ETF has fallen 36% and the S&P 500 has gained 13.5%."

More news about Nikkei 225 (N225).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com